Cargando…
Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy
Autores principales: | Dahiya, Saurabh, Luetkens, Tim, Lutfi, Forat, Avila, Stephanie, Iraguha, Thierry, Margiotta, Philip, Hankey, Kim G., Lesho, Patricia, Law, Jennie Y., Lee, Seung T., Baddley, John, Kocoglu, Mehmet, Yared, Jean A., Hardy, Nancy M., Rapoport, Aaron P., Atanackovic, Djordje |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709721/ https://www.ncbi.nlm.nih.gov/pubmed/34941995 http://dx.doi.org/10.1182/bloodadvances.2021006112 |
Ejemplares similares
-
Impaired mRNA Based COVID-19 Vaccine Response in Patients with B-Cell Malignancies after CD19 Directed CAR-T Cell Therapy
por: Dahiya, Saurabh, et al.
Publicado: (2021) -
Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell–depleted lymphoma after CART therapy
por: Atanackovic, Djordje, et al.
Publicado: (2022) -
Anti-SARS-CoV-2 Immune Responses in Patients Receiving an Allogeneic Stem Cell or Organ Transplant
por: Atanackovic, Djordje, et al.
Publicado: (2021) -
T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine
por: Atanackovic, Djordje, et al.
Publicado: (2022) -
Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD)
por: Kline, Kathryn, et al.
Publicado: (2023)